Search research articles
Contact Us
Filters
Showing results (161-170 of 390) with videos related to
Page
of 39
Sort By:
Nature Medicine
|
June 4, 2002
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Helmut Butzkueven, Jian-Guo Zhang, Merja Soilu-Hanninen, et al.
Plos One
|
January 4, 2014
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes
Anneke van der Walt, Scott C Kolbe, Yejun E Wang, et al.
Frontiers in Immunology
|
June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
Alexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Plos One
|
June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study
Emma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
Glia
|
February 23, 2008
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair
Mark P Marriott, Ben Emery, Holly S Cate, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
Ilya Kister, Tim Spelman, Raed Alroughani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve
Melissa M Gresle, Yaou Liu, Trevor J Kilpatrick, et al.
Brain : a Journal of Neurology
|
November 8, 2022
Novel plasma and brain proteins that are implicated in multiple sclerosis
Xin Lin, Yuanhao Yang, Melissa Gresle, et al.
Journal of Neurology
|
June 25, 2024
Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms
Sarah P Griffith, Robb Wesselingh, Nabil Seery, et al.
BMJ Neurology Open
|
May 13, 2024
Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic
Louise Rath, Wei Zhen Yeh, Angie Roldan, et al.
Page
of 39
Search research articles
Search
Showing results (161-170 of 390) with videos related to
Sort By:
Page
of 39
Nature Medicine
|
June 4, 2002
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Helmut Butzkueven, Jian-Guo Zhang, Merja Soilu-Hanninen, et al.
Plos One
|
January 4, 2014
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes
Anneke van der Walt, Scott C Kolbe, Yejun E Wang, et al.
Frontiers in Immunology
|
June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
Alexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Plos One
|
June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study
Emma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
Glia
|
February 23, 2008
Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair
Mark P Marriott, Ben Emery, Holly S Cate, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
Ilya Kister, Tim Spelman, Raed Alroughani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve
Melissa M Gresle, Yaou Liu, Trevor J Kilpatrick, et al.
Brain : a Journal of Neurology
|
November 8, 2022
Novel plasma and brain proteins that are implicated in multiple sclerosis
Xin Lin, Yuanhao Yang, Melissa Gresle, et al.
Journal of Neurology
|
June 25, 2024
Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms
Sarah P Griffith, Robb Wesselingh, Nabil Seery, et al.
BMJ Neurology Open
|
May 13, 2024
Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic
Louise Rath, Wei Zhen Yeh, Angie Roldan, et al.
Page
of 39